Simultaneous mass spectrum imaging method for halogenated alkane substances and biological metabolism small molecules
By using tetraphenylphosphine chloride as an ionization enhancement reagent in the aerodynamic auxiliary ionization mass spectrometry imaging system, the problem of in-situ ionization difficulty of halogenated alkanes is solved, and simultaneous mass spectrometry imaging of halogenated alkanes and biological metabolic small molecules is achieved Analysis improves analysis sensitivity and visualization effects.
Patent Information
- Application Number
- CN202310528509.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-11
- Publication Date
- 2024-11-12
AI Technical Summary
The prior art is difficult to perform in situ ionization of halogenated alkanes, which makes it difficult to analyze in mass spectrometry imaging analysis, and it is impossible to simultaneously analyze halogenated alkanes and biological metabolic small molecules.
In the aerodynamic auxiliary ionization mass spectrometry imaging system, by adding the ionization enhancement reagent tetraphenylphosphine chloride to the mobile phase, the formation of high-responsive adduct ions is promoted, thereby improving the analysis sensitivity and not affecting the small amount of biological metabolism. Detection of molecules.
The simultaneous mass spectrometry imaging analysis of halogenated alkanes and biological metabolic small molecules is realized. It has the characteristics of high sensitivity, rapid and simple, high visualization degree and rich spatial information, and can carry out halogenated alkanes and endogenous metabolic small molecules at low concentrations. Imaging and spatial co-localization.
Smart Images

Figure CN118937549A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of mass spectrometry imaging, and in particular is a method for simultaneously imaging halogenated alkane substances and biological metabolic small molecules. Background Art
[0002] Halogenated alkanes are an important industrial raw material and are widely used in the fields of chemical material synthesis and drug synthesis. However, halogenated alkanes are generally difficult to degrade and have strong environmental persistence. Many halogenated alkanes have been included in the POPs Convention or the list of new pollutants. The analysis of halogenated alkanes is generally based on gas chromatography. Due to their difficulty in ionizing in the ESI source, liquid phase analysis and mass spectrometry imaging are not possible.
[0003] Desorption electrospray ionization mass spectrometry imaging (DESI-MSI) has been widely used in the imaging analysis of polar small molecules, lipid molecules and drugs. The principle of aerodynamic assisted ionization mass spectrometry imaging (AFAI-MSI) is similar to that of DESI-MSI. It adds a high-speed air flow device, successfully realizes the long-distance transmission of the target to be measured, and removes background ions at the same time, reducing the interference caused by background ions. AFAI-MSI has the advantages of large-scale scanning, long-distance transmission, high sensitivity and low background interference. However, AFAI-MSI is more difficult to analyze halogenated alkane species because traditional mobile phase components make it difficult to ionize them in situ.
[0004] Therefore, we need to develop a method that allows the in situ ionization of halogenated alkanes for mass spectrometry imaging analysis without affecting the analysis of small molecules in biological metabolism. Summary of the invention
[0005] In order to solve the deficiencies of the above-mentioned technologies, the present invention has developed a method for simultaneous mass spectrometry imaging of halogenated alkanes and small molecules of biological metabolism. By adding the ionization enhancement reagent tetraphenylphosphine chloride to the mobile phase, halogenated alkanes can form highly responsive adduct ions in situ, thereby greatly improving their analytical sensitivity; at the same time, the addition of the reagent does not affect the detection of small molecules of biological metabolism, thereby realizing the simultaneous mass spectrometry imaging analysis of halogenated alkanes and small molecules of biological metabolism. The invention has the characteristics of high sensitivity, rapidity and simplicity, high degree of visualization, and rich spatial information.
[0006] Specifically, the technical solution provided by the present invention is as follows:
[0007] The present invention provides a method for simultaneous mass spectrometry imaging of halogenated alkanes and biological metabolic small molecules, comprising the following steps:
[0008] Making biological tissue sections;
[0009] The biological tissue slices were placed in an aerodynamically assisted ionization mass spectrometry imaging system for scanning analysis, and the scanning was carried out in a negative ion mode, and an ionization enhancement reagent tetraphenylphosphine chloride was added to the mobile phase;
[0010] The mass spectrometry imaging data files obtained by scanning and analysis are processed to obtain mass spectrometry imaging images of halogenated alkanes and small molecules of biological metabolism.
[0011] Preferably, the preparation of biological tissue sections comprises: firstly, embedding the biological tissue with an embedding agent, freezing and slicing it to obtain frozen sections, adhering them to a positively charged anti-shedding glass slide, and drying the sections to obtain dried biological tissue sections.
[0012] Preferably, in the preparation of biological tissue sections, the biological tissue needs to be quickly frozen with liquid nitrogen to prevent changes in the content of metabolic molecules; after the samples are collected, they need to be stored in a -80°C ultra-low temperature refrigerator and taken out when slicing.
[0013] Preferably, the embedding agent is a sodium carboxymethylcellulose solution with a mass concentration of 1%-5%; or a gelatin solution with a mass concentration of 5%-10%; or a mixed solution of sodium carboxymethylcellulose and gelatin, wherein the sodium carboxymethylcellulose solution has a better effect.
[0014] Preferably, a 30mm×20mm×12mm disposable mold can be used for embedding; the mold and the embedded biological tissue are placed in a -20°C freezing microtome for 20 to 60 minutes, and the slices can be cut only after the embedding agent is completely solidified, and the thickness of the frozen slices is 20-40μm; the cut slices need to be stored in a -80°C ultra-low temperature refrigerator and taken out for imaging analysis.
[0015] Preferably, the drying process is vacuum drying, and the drying time is 15-30 minutes.
[0016] Preferably, the mobile phase is 100% methanol, the concentration of the ionization enhancement reagent tetraphenylphosphine chloride is 50-300 μM; and the flow rate of the mobile phase is 3-10 μL / min.
[0017] Preferably, in the scanning analysis, the parameters at the ion source are set as follows: the moving speed in the x-direction is 50-500μm / s, the moving distance in the y-direction is 50-500μm, the exhaust gas flow rate is 20-40L / min, the spray pressure is 0.5-0.9MPa, the spray voltage is 0 to -8000V, the extension length of the spray needle is 0.2-0.4mm, the angle between the nozzle and the slide is 60-70°, and the nozzle height is 1-4mm, so as to form a relatively solid feather-shaped or elliptical spray point on the slide for the best result.
[0018] Preferably, in the scanning analysis, the parameters of the mass spectrometer are set as follows: scanning range is 80-1200Da, sheath gas flow rate is 0, auxiliary gas flow rate is 0, purge gas flow rate is 0, ion transfer tube temperature is 250-350°C, scanning mode is FullMS, AGC target is 1e5-5e6, and ion mode is Negative.
[0019] Preferably, the software used to process the mass spectrometry imaging data file includes Xcalibur (for converting .raw files into .cdf files) and MassImager (for generating mass spectrometry imaging images). In MassImager, the H&E staining image of the sample can be overlapped with the mass spectrometry imaging image, so that each organ / substructure can be distinguished for analysis.
[0020] The beneficial effects of the present invention are as follows:
[0021] The present invention adds an ionization enhancement reagent tetraphenylphosphine chloride to the mobile phase. The tetraphenylphosphine structure of the reagent easily releases chloride ions, thereby promoting the formation of halogenated alkane substances [M+Cl] - The adducted ions greatly improve the analytical sensitivity of halogenated alkanes in the aerodynamic assisted ionization mass spectrometry imaging system, realize the simultaneous imaging of halogenated alkanes and biological metabolic small molecules, and can simultaneously image and spatially co-localize low-concentration halogenated alkanes (ng / mL level) and endogenous metabolic small molecules in zebrafish and other biological tissue slices. The mass spectrometry imaging method provided by the present invention only requires slicing of the sample and has no other pre-treatment requirements. It does not affect the detection of metabolic small molecules while highly sensitively characterizing the substance, and has the characteristics of high sensitivity, rapidity and simplicity, high degree of visualization, and rich spatial information. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] Figure 1 Schematic representation of the analysis performed in Example 1 in the AFAI-MSI system.
[0023] Figure 2 The results are the optimization results of the parameters in Example 1 regarding the concentration of phosphine salt, the ratio of methanol to water in the mobile phase, the pumping gas flow rate, the spray pressure and the spray voltage.
[0024] Figure 3 is the SCCP (C 13 H 21 Cl7), MCCP (C 16 H 27 Cl7), HBCD(C 12 H 18 Br6), Chlordecone (C 10 Cl 10 O), trans clone (C 18H 12 Cl 12 )、endosulfan (C9H6Cl6SO3), aCl11DP (C 18 H 13 Cl 11 )、aCl10DP(C 18 H 14 Cl 10 ) Standard sample concentration gradient imaging diagram and mass spectrum at the lowest concentration that can be imaged.
[0025] Figure 4 This is the mass spectrometry image of SCCPs, MCCPs and HBCD in zebrafish in Example 1.
[0026] Figure 5 This is the full scan mass spectrum of zebrafish mass spectrometry imaging in negative ion mode in Example 1.
[0027] Figure 6 is the SCCP (C 13 H 21 Cl7), MCCP (C 14 H 23 Cl7), HBCD(C 12 H 18 Figure 3. Mass spectrometry images of Br6 in zebrafish, mass spectrometry images of metabolites (FA (18:1), inosine, and PE (38:6) as examples), corresponding H&E staining images, and overlapping images of pollutants, metabolites, and H&E staining images.
[0028] Figure 7 The control group and the SCCPs exposure group (C 12 H 19 Cl7), MCCPs exposure group (C 14 H 22 Cl8), HBCD exposure group (C 12 H 18 Br6) Mass spectrometry images of pollutants at various sampling times.
[0029] Figure 8 The concentration ratios of SCCPs, MCCPs and HBCD in various organs when the exposure time is 24 days in Example 1.
[0030] Fig. 9 is the SCCP (C 12 H 19 Cl7), MCCP (C 14 H 22 Cl8)、HBCD(C 12 H 18Changes in Br6 concentrations in liver, ovary, and brain with exposure time.
[0031] Fig.10 This is a heat map of the fold change (FC) of endogenous molecules in each organ on the 24th day that were significantly different on the 17th and 24th days under exposure to the three pollutants in Example 1, and their mutual conversion relationships (based on the KEGG network).
[0032] Fig.11 This is a comparison of the imaging of different metabolic molecules affected by different pollutants in Example 1. DETAILED DESCRIPTION
[0033] In order to better illustrate the present invention, a mass spectrometry imaging technology for simultaneously imaging halogenated alkane pollutants and metabolic small molecules will be described in detail below with reference to the accompanying drawings and examples.
[0034] Example 1
[0035] Female zebrafish and fish eggs exposed to environmental concentrations of short-chain paraffins (SCCPs), medium-chain paraffins (MCCPs), and hexabromocyclododecane (HBCD) were sliced and imaged by mass spectrometry in order to analyze their toxicokinetics and toxicodynamics. The steps are as follows:
[0036] 1. Zebrafish exposure experiment. The exposure experiment was carried out in a crystal dish with a diameter of 180 mm, with three female zebrafish in one dish. The exposure liquid volume in each dish was 1L, and aquaculture water was used as the exposure liquid. SCCPs selected a mixed standard with a chlorine content of 55.5%, and MCCPs selected a mixed standard with a chlorine content of 52%. The exposure concentrations of the three pollutants were all 10 ng / mL. Both the exposure group and the control group contained 0.1% DMSO. Static exposure was adopted, and the exposure liquid was changed once a day. Feeding was performed 2 hours before changing the exposure liquid. Collect 3 fish each on the 3rd, 10th, and 17th days of exposure. On the 24th day after the exposure, mate with the unexposed male fish. After spawning, collect the 3 female fish and the eggs, and discard the male fish.
[0037] 2. Use liquid nitrogen to freeze the sample quickly to prevent changes in the content of metabolic molecules, and store it in a -80℃ ultra-low temperature refrigerator until it is taken out for slicing. Use 3% sodium carboxymethyl cellulose solution as an embedding agent to embed the fish for slicing, and a 30mm×20mm×12mm disposable mold can be used. First, squeeze a layer of embedding agent on the bottom of the mold, put the zebrafish in, and continue to squeeze in the embedding agent until the zebrafish is completely covered. The embedding of fish eggs is similar. Place the mold and the embedded zebrafish in a -20℃ freezing microtome for 20 minutes until the embedding agent is completely solidified before slicing. The optimal thickness of the frozen section is 40μm. The cut slices must be stored in a -80℃ ultra-low temperature refrigerator and taken out for imaging analysis. When analysis is required, the slices are vacuum dried for 15 minutes to obtain dry zebrafish slices.
[0038] 3. Place the slices in an aerodynamic assisted ionization mass spectrometry imaging system for scanning analysis. The mobile phase is 100% methanol, and the concentration of the ionization enhancement reagent tetraphenylphosphine chloride is 150μM. The mobile phase flow rate is 5μL / min. The parameters at the ion source are set as follows: the moving speed in the x direction is 200μm / s, the moving distance in the y direction is 200μm, the pumping flow rate is 40L / min, the spray pressure is 0.6MPa, and the spray voltage is -6000V. The needle extension length is 0.3mm, the angle between the nozzle and the slide is 65°, and the nozzle height is 2mm. At this time, a relatively solid feather-shaped or elliptical spray point can be formed on the slide. The parameters at the mass spectrometer end are set as follows: the scanning range is 80-1200Da, the sheath gas flow rate is 0, the auxiliary gas flow rate is 0, the purge gas flow rate is 0, the ion transfer tube temperature is 350℃, the scanning mode is Full MS, the AGC target is 1e5, and the ion mode is Negative. The analysis was performed using the AFAI-MSI system coupled with Orbitrap-MS. Figure 1 As shown, by adding the ionization enhancement reagent tetraphenylphosphine chloride to the mobile phase, halogenated alkanes can form highly responsive adduct ions in situ, thereby greatly improving their analytical sensitivity; at the same time, the addition of this reagent does not affect the detection of biological metabolic small molecules, thereby realizing the simultaneous mass spectrometry imaging analysis of halogenated alkanes and biological metabolic small molecules.
[0039] Preferably, in this embodiment, the concentration of tetraphenylphosphine chloride and the ratio of methanol to water in the mobile phase are optimized. The optimized concentration of tetraphenylphosphine chloride is 5, 50, 100, 150, 300 μM, and the best is 150 μM; the optimized ratio of methanol to water in the mobile phase is 80:20, 90:10, 95:5, 100:0, and the best is 100:0. In addition, the pumping flow rate, spray pressure and spray voltage are also optimized. The optimized values of the air flow rate are 20, 25, 30, 35, 40 L / min, and the best is 40 L / min; the optimized values of the spray pressure are 0.5, 0.6, 0.7, 0.8, 0.9 MPa, and the best is 0.6 MPa; the optimized values of the spray voltage are 0, -1000, -2000, -3000, -4000, -5000, -6000, -7000, -8000 V, and the best is -6000 V. The optimization results are shown in Figure 2. Figure 2 shown.
[0040] In particular, in this embodiment, in order to semi-quantitate the pollutants in zebrafish, imaging scans of pollutant standards of different concentrations are performed. Preferably, 1 μL of the standard sample is dripped onto the dot plate and allowed to air dry naturally. The concentration gradient of the standard sample is 10, 100, 1000, and 10000 ng / mL. The parameters at the ion source and the mass spectrometer end are consistent with the above parameters. Figure 3 The SCCP (C 13 H 21 Cl7), MCCP (C 16 H 27 Cl7), HBCD(C 12 H 18 Br6), Chlordecone (C 10 Cl 10 O), trans clone (C 18 H 12 Cl 12 )、endosulfan (C9H6Cl6SO3), aCl11DP (C 18 H 13 Cl 11 )、aCl10DP(C 18 H 14 Cl 10 ) standard sample concentration gradient imaging diagram and mass spectrum at the lowest concentration that can be imaged, and the signal-to-noise ratio (S / N) of the response was calculated. 13 H 21 Cl7), the lowest concentration was 10 ng / mL, and the S / N was 39; for MCCP (C 16 H 27 Cl7), the lowest concentration is 2ng / mL, and the S / N is 21; for HBCD (C 12 H18 Br6), the lowest concentration was 100 ng / mL, and the S / N was 73; for chlordecone (C 10 Cl 10 O), the lowest concentration was 10 ng / mL, and the S / N was 27; for the trans clone (C 18 H 12 Cl 12 ), the minimum concentration was 100 ng / mL, and the S / N was 9.2; for endosulfan (C9H6Cl6SO3), the minimum concentration was 1000 ng / mL, and the S / N was 23; for aCl11DP (C 18 H 13 Cl 11 ), the lowest concentration was 10 ng / mL, and the S / N was 3.9; for aCl10DP (C 18 H 14 Cl 10 ), the lowest concentration that can be imaged is 100 ng / mL, and its S / N is 3.2.
[0041] 4. Process the obtained mass spectrometry imaging data file to obtain an imaging ion image. The software includes Xcalibur (for converting .raw files into .cdf files) and MassImager (for generating mass spectrometry imaging images). In MassImager, the optical image / H&E staining image of the sample can be overlapped with the ion imaging image, thereby dividing each organ of zebrafish for analysis. In the present embodiment, nine organs including liver, intestinal tract, gill, ovary, kidney, heart, eye, brain and muscle are concerned. The pollutants and metabolic molecules of each organ are analyzed to obtain its toxicokinetic results and toxicodynamic results.
[0042] like Figure 4 As shown in the figure, it is the mass spectra of SCCPs, MCCPs, and HBCD in zebrafish. It can be seen that the three pollutants have clear and reasonable isotope patterns. This method not only successfully analyzes the three pollutants, but also can analyze endogenous molecules, including polar small molecules and lipid molecules, such as Figure 5 The full scan mass spectrum of zebrafish mass spectrometry imaging in negative ion mode is shown, which provides rich material information. Figure 6 Demonstrated SCCP (C 13 H 21 Cl7), MCCP (C 14 H 23 Cl7), HBCD(C 12 H 18Mass spectrometry images of Br6 in zebrafish, mass spectrometry images of metabolites (FA (18:1), inosine, and PE (38:6) as examples), corresponding H&E staining images, and overlapping images of pollutants, metabolites, and H&E staining images. After overlapping, each organ can be divided for analysis.
[0043] Toxicokinetic analysis of contaminants was performed. Figure 7 The control group and SCCPs exposure group (C 12 H 19 Cl7), MCCPs exposure group (C 14 H 22 Cl8), HBCD exposure group (C 12 H 18 Br6) Mass spectrometry images of pollutants at different sampling times. It can be seen that different pollutants have different accumulation characteristics in different organs at different times. Figure 8 The figure shows the concentration ratio of total SCCPs, total MCCPs and HBCD in each organ when the exposure time is 24 days. It can be seen that the enrichment ability of different pollutants in different organs is different. Focusing on each organ, the concentration changes of each pollutant in each organ with the exposure time are analyzed, such as Fig. 9 The SCCP (C 12 H 19 Cl7), MCCP (C 14 H 22 Cl8)、HBCD(C 12 H 18 The concentration of Br6) in the liver, ovary and brain changes with exposure time. It can be seen that the concentration changes of different pollutants in various organs are different. For SCCP, SCCP reaches the peak concentration in all three organs at 10 days of exposure; for MCCP, the three organs are different; for HBCD, they all show a gradual upward trend with exposure time.
[0044] Toxicodynamic analysis of pollutants was performed. Fig.10What is shown is that endogenous metabolic molecules with significant differences at 17 days and 24 days of exposure were screened out, and based on the fold change on the 24th day, heat maps of each molecule in each organ under different pollutant exposure were drawn; at the same time, the conversion relationship of these molecules was drawn based on the KEGG network. It can be seen from the heat map that HBCD mainly affects proline-related metabolic molecules and lipid metabolism. HBCD upregulated proline-related metabolism; for lipid metabolism, HBCD downregulated intestinal phospholipids and upregulated intestinal glycerides, while other organs were the opposite to the intestine. MCCPs mainly affected polyamine-related metabolic molecules and lipid metabolism, both of which significantly downregulated the above pathways. SCCPs mainly affected lipid metabolism, causing it to downregulate, but the intensity of the downregulation was not as strong as MCCPs. Fig.11 The images show the impact of different pollutants on different metabolic molecules.
[0045] The above embodiment uses zebrafish as an example to illustrate the implementation process of the simultaneous mass spectrometry imaging method of a halogenated alkane substance and a biological metabolic small molecule of the present invention. It is easy to understand that the method of the present invention is also applicable to other biological tissues other than zebrafish. By adding the ionization enhancement reagent tetraphenylphosphine chloride to the mobile phase and combining it with the mass spectrometry imaging analysis of aerodynamic assisted ionization, low-concentration halogenated alkanes (ng / mL level) and endogenous metabolic small molecules can be imaged and spatially co-localized in other biological tissue sections.
[0046] The specific embodiments of the present invention disclosed above are intended to help understand the content of the present invention and implement it accordingly. It can be understood by those skilled in the art that various replacements, changes and modifications are possible without departing from the spirit and scope of the present invention. The present invention should not be limited to the contents disclosed in the embodiments of this specification, and the scope of protection of the present invention shall be subject to the scope defined in the claims.
Claims
1. A method for simultaneous mass spectrometry imaging of halogenated alkanes and biological metabolic small molecules, comprising the following steps: Making biological tissue sections; The biological tissue slices were placed in an aerodynamically assisted ionization mass spectrometry imaging system for scanning analysis, and the scanning was carried out in a negative ion mode, and an ionization enhancement reagent tetraphenylphosphine chloride was added to the mobile phase; The mass spectrometry imaging data files obtained by scanning and analysis are processed to obtain mass spectrometry imaging images of halogenated alkanes and small molecules of biological metabolism.
2. The method according to claim 1, characterized in that The method for preparing biological tissue slices comprises: embedding the biological tissue with an embedding agent, freezing and slicing the biological tissue to obtain frozen slices, adhering the frozen slices to a positively charged anti-shedding glass slide, and then drying the slices to obtain dried biological tissue slices.
3. The method according to claim 2, characterized in that The biological tissue is quickly frozen with liquid nitrogen when sampling to prevent changes in the content of metabolic molecules. After sampling, it is stored in a -80°C ultra-low temperature refrigerator and taken out when slicing; the embedding freezing is to place the mold and the embedded zebrafish in a -20°C freezing slicer for 20 minutes to 60 minutes until the embedding agent is completely solidified; the frozen slices are stored in a -80°C ultra-low temperature refrigerator and taken out when imaging analysis is performed; the thickness of the frozen slices is 20-40 μm.
4. The method according to claim 2, characterized in that The embedding agent is a sodium carboxymethylcellulose solution with a mass concentration of 1%-5%; or a gelatin solution with a mass concentration of 5%-10%; or a mixed solution of sodium carboxymethylcellulose and gelatin.
5. The method according to claim 2, characterized in that The drying process is vacuum drying, and the drying time is 15-30 minutes.
6. The method according to claim 1, characterized in that The mobile phase in the negative ion mode is 100% methanol, and the concentration of the ionization enhancement reagent tetraphenylphosphine chloride is 50-300 μM.
7. The method according to claim 1, characterized in that The flow rate of the mobile phase for the scanning analysis was 3-10 μL / min.
8. The method according to claim 1, characterized in that The parameters at the ion source of the scanning analysis are set as follows: the moving speed in the x-direction is 50-500 μm / s, the moving distance in the y-direction is 50-500 μm, the exhaust gas flow rate is 20-40 L / min, the spray pressure is 0.5-0.9 MPa, the spray voltage is 0 to -8000 V, the extension length of the spray needle is 0.2-0.4 mm, the angle between the nozzle and the slide is 60-70°, and the nozzle height is 1-4 mm, so that a relatively solid feather-shaped or elliptical spray point can be formed on the slide for the best result.
9. The method according to claim 1, characterized in that For the scanning analysis, the parameters of the mass spectrometer were set as follows: scanning range 80-1200Da, sheath gas flow rate 0, auxiliary gas flow rate 0, purge gas flow rate 0, ion transfer tube temperature 250-350°C, scanning mode Full MS, AGC target 1e5-5e6, and ion mode Negative.
10. The method according to claim 1, characterized in that The mass spectrometry imaging data file obtained by the processing scanning analysis uses software including Xcalibur and MassImager, wherein Xcalibur is used to convert the .raw file into a .cdf file, and MassImager is used to generate a mass spectrometry imaging image; in MassImager, the H&E staining image of the sample is overlapped with the mass spectrometry imaging image to distinguish various organs / substructures for analysis.
